Healthy Skepticism Library item: 2505
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
[No authors listed].
Is Yasmin a 'truly different' drug?
Drug Ther Bull 2002 Aug; 40:(8):57-9
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12216337
Abstract:
A combined oral contraceptive (COC) containing the progestogen drospirenone (pronounced dro-spi-re-known) plus the oestrogen ethinylestradiol ([symbol: see text] Yasmin—Schering Health Care) is now available in the UK. Company advertising claims that Yasmin is “truly different”, as reliable and safe as other COCs and is “the pill for well-being”, with “no associated weight gain” and “a demonstrable positive effect” on premenstrual symptoms and skin condition. Such claims have also appeared in the lay media. Are they justified?
Keywords:
Adolescent
Adult
Aldosterone Antagonists
Androstenes*
Body Weight/drug effects
Contraceptives, Oral, Combined*
Female
Humans
Progesterone Congeners*
Randomized Controlled Trials
*analysis
United Kingdom
combination drugs
contraception
Schering
PROMOTION IN SPECIFIC THERAPEUTIC AREAS: BREAST FEEDING AND CONTRACEPTION
PROMOTION DISGUISED: PRESS CONFERENCES AND PRESS COVERAGE
